Cargando…
Patient perspective: my rare disease journey
My underlying diagnosis since birth was congenital muscular dystrophy not otherwise specified. Being born in 1970 meant that there were no genetic testing, no standards of care, and no true understanding of the pathology that separates one congenital-onset neuromuscular disorder from the next. Two m...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958917/ https://www.ncbi.nlm.nih.gov/pubmed/35217566 http://dx.doi.org/10.1101/mcs.a006205 |
Sumario: | My underlying diagnosis since birth was congenital muscular dystrophy not otherwise specified. Being born in 1970 meant that there were no genetic testing, no standards of care, and no true understanding of the pathology that separates one congenital-onset neuromuscular disorder from the next. Two muscle biopsies described histological abnormalities of small type 1 fibers and were among the first of M.H. Brooke's cases described as congenital fiber-type disproportion (Brooke, Experta Medica 295: 147 [1973]). |
---|